Standout Papers

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell d... 2010 2026 2015 2020 1.0k
  1. Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients (2010)
    Julien Fourcade, Zhaojun Sun et al. The Journal of Experimental Medicine
  2. TIGIT and PD-1 impair tumor antigen–specific CD8+ T cells in melanoma patients (2015)
    Joë-Marc Chauvin, Ornella Pagliano et al. Journal of Clinical Investigation
  3. Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity (2017)
    Abigail E. Overacre-Delgoffe, Maria Chikina et al. Cell
  4. Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity (2024)
    Anthony R. Cillo, Carly Cardello et al. Cell

Immediate Impact

37 by Nobel laureates 13 from Science/Nature 148 standout
Sub-graph 1 of 17

Citing Papers

Principles and therapeutic applications of adaptive immunity
2024 Standout
LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunity
2024 Standout
17 intermediate papers

Works of Cindy Sander being referenced

Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity
2024 Standout
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients
2010 Standout
and 4 more

Author Peers

Author Last Decade Papers Cites
Cindy Sander 3642 3548 1129 82 5.1k
Matthew D. Vesely 2330 2541 911 50 4.0k
Hirokazu Matsushita 2640 3898 1242 89 5.2k
Jianda Yuan 3437 3399 1088 90 5.2k
Mary Philip 2654 2884 1203 60 4.7k
Vaios Karanikas 2348 2674 1265 50 4.0k
Tara C. Gangadhar 2933 1726 1014 75 3.9k
Yulia Nefedova 2134 3790 1901 53 5.6k
Andrea Schietinger 3028 3382 1164 41 4.9k
Viktor Umansky 2735 3438 1664 91 5.4k
Alexander C. Huang 2517 2481 922 40 3.8k

All Works

Loading papers...

Rankless by CCL
2026